Trial · NCT07897045
Dural Puncture Epidural With 27G vs 26G Needles Versus Standard Epidural for Elective Cesarean Delivery
NCT07897045, Not applicable, Not yet recruiting, Ankara City Hospital Bilkent
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Dural Puncture Epidural With 27G vs 26G Needles Versus Standard Epidural for Elective Cesarean Delivery. Trials, record NCT07897045. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07897045
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Dural Puncture Epidural With 27G vs 26G Needles Versus Standard Epidural for Elective Cesarean Delivery
- NCT number
- NCT07897045
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 165 participants, estimated
- Lead sponsor
- Ankara City Hospital Bilkent
- Conditions
- Cesarean Section, Anesthesia, Obstetrical, Anesthesia, Epidural
- Interventions
- Standard Epidural Anesthesia, Dural Puncture Epidural With 27G Spinal Needle, Dural Puncture Epidural With 26G Spinal Needle
- First posted
- 2026-10-27
- Last updated
- 2026-10-27
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Onset time of surgical anesthesia | From t0 up to 20 minutes | Time (minutes) from completion of epidural drug injection (t0) to bilateral loss of pinprick sensation at the T5 dermatome, assessed every minute. |
| Secondary | Incidence of hypotension | From t0 to 50 minutes | Proportion of patients with systolic blood pressure \<90 mmHg or \>20% decrease from baseline. |
| Secondary | Intraoperative ephedrine requirement | From t0 to end of surgery (assessed up to 50 minutes) | Total ephedrine dose (mg). |
| Secondary | Need for additional epidural local anesthetic | From t0 to end of surgery (assessed up to 50 minutes) | Proportion of patients requiring a supplemental epidural dose and total supplemental dose (mg). |
| Secondary | Motor block intensity | From t0 to 50 minutes | Modified Bromage score (0=no motor block, 4=complete blokck of motor limb) |
| Secondary | Motor block recovery time | Postoperative, up to 24 hours | Time (minutes) from t0 to Bromage score transitions 3→2, 2→1 and 1→0. |
| Secondary | Sensory block regression time | Postoperative, up to 24 hours | Time (minutes) from t0 to two-segment regression and regression of sensory block to T10, L1 and S2. |
| Secondary | Post-dural puncture headache | 24 and 48 hours after surgery | Incidence and severity of postural headache (Visuel analogue score (VAS) 0-10).(VAS=0 no pain, VAS=10 unbearable pain) |
| Secondary | Blood pressure | Every minute for 15 minutes, then every 5 minutes up to 50 minutes | Systolic, diastolic and mean arterial pressure, in mmHg |
| Secondary | heart rate | Every minute for 15 minutes, then every 5 minutes up to 50 minutes | the number of times heart beats per minute , pulse/min |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07897045
GET https://conductscience.org/api/trials/v1/NCT07897045/registered